Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues. But according to a recent study, those benefits fade within two years of patients stopping their treatment.
According to a study published in the BMJ, data from 9,341 obese or overweight patients treated in 37 studies with any of 18 different weight-loss drugs showed that they regained about one pound on average after stopping the drugs.
The same study said they were projected to return to their pre-treatment weight in about two years.
But weight was not the only thing that was projected to return after stopping the treatment. According to the same study, health risk factors like blood pressure and cholesterol levels, which saw benefits while taking the drugs, were projected to return to their old levels within 1.4 years.
GLP-1 medications tested as well
About half of the patients studied took newer GLP-1 drugs like semaglutide, sold as Ozempic and Wegovy, as well as tirzepatide, which is sold as Mounjaro and Zepbound. According to the study, the weight regain rate was faster for these drugs, with an average of 1.8 pounds per month.
“But because people on semaglutide or tirzepatide lose more weight in the first place, they all end up returning to baseline at approximately the same time,” study senior researcher Dimitrios Koutoukidis of Oxford University told Reuters.
Weight loss drugs have shown some success
Weight loss drugs like the ones tested in the study have shown large levels of success in the United States in recent years. Back in October 2025, a survey from the Gallup National Health and Well-Being Index showed that there were an estimated 7.6 million fewer obese people in the United States compared to 2022.
In 2022, the U.S. adult obesity rate was a record-high 39.9%, while in 2025, that rate gradually declined to 37%. While the obesity rate dropped, the usage of GLP-1 drugs like Ozempic and Wegovy doubled between 2025 and 2024, according to the same study.
Contributing: Nicole Fallert, USA TODAY; Reuters
Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at [email protected] and follow him on X @fern_cerv_.
This article originally appeared on USA TODAY: Here's how fast you can gain weight after ending GLP-1, per study
latest_posts
- 1
2026 will be the year NASA astronauts fly around the moon again — if all goes to plan - 2Beating Scholastic Difficulties: Understudy Examples of overcoming adversity
- 3Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- 4Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It
- 5Ski Resorts Universally: A Colder time of year Wonderland Guide
- Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- The Leonid meteor shower is peaking early this week. Here’s what to know
- People Are Sharing The One Picture They Can't See Without Laughing, And It's The Comedy Spiral You Need Today
- The risk of falling space junk hitting airplanes is on the rise, experts warn
- U.S. overhauls childhood vaccine schedule, recommends fewer shots
- Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
- Vote In favor of Your Favored Kind Of Cheddar
- Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
